| | | | | |

New Article Faults “Unsound Science” for Continued Rise in Mesothelioma Cases

24174143_asbestos3A German occupational medicine specialist says the rules regarding eligibility for mesothelioma compensation – many of which are based on “unsound science” – are too strict and leave too many mesothelioma patients out.

According to Xaver Bauer, MD, of the Institute of Occupational Medicine at Charite University Hospital in Berlin, a case in point is the “unscientific requirement” for a set number of asbestos fibers to be found in the lung tissue of mesothelioma patients to prove that asbestos caused their disease.

Although the validity of such evidence has been discredited by independent scientists, it is still used as evidence by an influential US pathology department,” writes Bauer in the German medical journal Pneumologie.

Asbestos Exposure and Mesothelioma

Heat and corrosion-resistant asbestos was once widely used as an insulator and in hundreds of construction and even household products. Exposure to asbestos is now  the number one cause of mesothelioma worldwide and accounts for an estimated eight to fifteen percent of lung cancer cases.

Many mesothelioma victims were exposed to the deadly toxin by negligent companies which failed to provide them with the necessary training or protective gear to shield them from asbestos. But seeking mesothelioma compensation from these companies is often not as straightforward as it should be, especially if important data is not considered.

“Frequently, epidemiological evidence regarding causal relationships and exposure histories is also often being ignored by insurance-affiliated medical experts,” writes Bauer.

Misleading Arguments for “Safer” Asbestos

Another misleading scientific argument that can impact compensation and even delay diagnosis is the idea that some kinds of asbestos are “safer” than others.

Especially in newly-industrialized countries such as South Africa, Brazil, and the Philippines, there is an idea circulating that chrysotile or “white” asbestos – the most commonly-used type of asbestos in the world – is less likely to cause mesothelioma.

As a result, Bauer points out that asbestos use is rising in some of these countries, along with the incidence of mesothelioma. According to Bauer, such economically-driven misinformation campaigns “discount the ensuing damage to health and the impact of the diseases they create on public health systems.”

All types of asbestos have been linked to mesothelioma, a rare but treatment-resistant cancer that continues to impact tens of thousands of people around the world every year, including approximately 2,500 in the US.

Although the US has yet to ban asbestos, the Environmental Protection Agency (EPA) and the National Occupational Safety and Health Administration (NIOSH) acknowledge that no level of asbestos exposure is “safe” and have instituted strict rules for its use, handling and disposal to minimize the risk for mesothelioma.

Source:

Bauer, X, “Asbestos: Socio-legal and Scientific Controversies and Unsound Science in the Context of the Worldwide Asbestos Tragedy – Lessons to be Learned”, April 28, 2016, Pneumologie, Epub ahead of print,

Similar Posts

  • | |

    Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers

    Paul Kraus is considered the longest documented mesothelioma survivor in the world. He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. Not willing to give up, he worked with a team of doctors to create his own tailored treatment protocol. This protocol included dramatic life style change, experimental therapies, dietary changes, mind-body medicine, and other modalities. Paul was fortunate. The protocol he and his doctors created helped him keep the mesothelioma in check. His book “Surviving Mesothelioma and Other Cancers: A Patient’s Guide” details his cancer voyage, the decisions he made, and his philosophies about health and healing. This book is now the best-selling mesothelioma book in the world and has inspired…

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…